BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 11128692)

  • 21. Pulmonary edema and possible pneumonitis associated with celecoxib.
    Olin JL; Chan A; Lazarus DS
    Ann Pharmacother; 2004 Jun; 38(6):1086. PubMed ID: 15122006
    [No Abstract]   [Full Text] [Related]  

  • 22. [Effect of celecoxib, a COX-2 inhibitor, in familial adenomatous polyposis].
    Wullen B; Mühlhöfer A; Zoller WG
    Z Gastroenterol; 2001 Apr; 39(4):335-7. PubMed ID: 11367984
    [No Abstract]   [Full Text] [Related]  

  • 23. Efficacy and safety of COX 2 inhibitors.
    Jones R
    BMJ; 2002 Sep; 325(7365):607-8. PubMed ID: 12242157
    [No Abstract]   [Full Text] [Related]  

  • 24. Induction of apoptosis in rheumatoid synovial fibroblasts by celecoxib, but not by other selective cyclooxygenase 2 inhibitors.
    Kusunoki N; Yamazaki R; Kawai S
    Arthritis Rheum; 2002 Dec; 46(12):3159-67. PubMed ID: 12483719
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [COX-2 inhibitors: a new treatment in rheumatic diseases].
    Puddu G; Cravero E
    Clin Ter; 2003; 154(1):39-43. PubMed ID: 12854282
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Celecoxib-induced acute pancreatitis and hepatitis: a case report.
    Carrillo-Jimenez R; Nurnberger M
    Arch Intern Med; 2000 Feb; 160(4):553-4. PubMed ID: 10695699
    [No Abstract]   [Full Text] [Related]  

  • 27. [New anti-inflammatory analgetics--are they needed?].
    Paakkari I
    Duodecim; 1999; 115(20):2217-24. PubMed ID: 11973925
    [No Abstract]   [Full Text] [Related]  

  • 28. Cyclooxygenase 2 selective inhibitor induced bowel stricture: a case report.
    Mir O; Dhote R; Scavennec R; Ropert S; Christoforov B
    Gut; 2004 Jan; 53(1):154. PubMed ID: 14684594
    [No Abstract]   [Full Text] [Related]  

  • 29. Relationship between selective cyclooxygenase-2 inhibitors and acute myocardial infarction in older adults.
    Solomon DH; Schneeweiss S; Glynn RJ; Kiyota Y; Levin R; Mogun H; Avorn J
    Circulation; 2004 May; 109(17):2068-73. PubMed ID: 15096449
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the baseline cardiovascular risk profile among hypertensive patients prescribed COX-2-specific inhibitors or nonspecific NSAIDs: data from real-life practice.
    Zhao SZ; Burke TA; Whelton A; von Allmen H; Henderson SC
    Am J Manag Care; 2002 Oct; 8(15 Suppl):S392-400. PubMed ID: 12416789
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cyclooxygenase-2 inhibition and renal function.
    Pfister AK; Crisalli RJ; Carter WH
    Ann Intern Med; 2001 Jun; 134(11):1077; author reply 1078. PubMed ID: 11388824
    [No Abstract]   [Full Text] [Related]  

  • 32. [Tolerable pain therapy in rheumatism saves long-term costs. Despite this most COX-2 candidates receive conventional NSAID therapy].
    MMW Fortschr Med; 2003 Jul; 145(29-30):61. PubMed ID: 12958786
    [No Abstract]   [Full Text] [Related]  

  • 33. Selective cyclo-oxygenase-2 inhibitor-induced oliguria: a postoperative complication.
    Smiles J; Walker R
    Intern Med J; 2001 Nov; 31(8):497-8. PubMed ID: 11720066
    [No Abstract]   [Full Text] [Related]  

  • 34. Cost of heart failure among hypertensive users of nonspecific NSAIDs and COX-2-specific inhibitors.
    Zhao SZ; Burke TA; Whelton A; von Allmen H; Henderson SC
    Am J Manag Care; 2002 Oct; 8(15 Suppl):S414-27. PubMed ID: 12416791
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Celecoxib: a potent cyclooxygenase-2 inhibitor in cancer prevention.
    Kismet K; Akay MT; Abbasoglu O; Ercan A
    Cancer Detect Prev; 2004; 28(2):127-42. PubMed ID: 15068837
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduced incidence of upper gastrointestinal ulcer complications with the COX-2 selective inhibitor, valdecoxib.
    Goldstein JL; Eisen GM; Agrawal N; Stenson WF; Kent JD; Verburg KM
    Aliment Pharmacol Ther; 2004 Sep; 20(5):527-38. PubMed ID: 15339324
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New reports on dental analgesics. NSAIDs and cardiovascular effects, celecoxib for dental pain, and a new analgesic--tramadol with acetaminophen.
    Wynn RL
    Gen Dent; 2002; 50(3):218-20, 22. PubMed ID: 12116507
    [No Abstract]   [Full Text] [Related]  

  • 38. [Clinical pharmacology of selective inhibitors of cyclooxygenase-2].
    Patrignani P
    Acta Otorhinolaryngol Ital; 2003 Aug; 23(4 Suppl 74):13-8, 37-40. PubMed ID: 15058604
    [No Abstract]   [Full Text] [Related]  

  • 39. [COX-2 inhibitor non-steroidal anti-inflammatory drugs, myth or reality?].
    Peretz A
    Rev Med Brux; 2001 Sep; 22(4):A377-80. PubMed ID: 11680204
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Longer use of COX-2-specific inhibitors compared to nonspecific nonsteroidal antiinflammatory drugs: a longitudinal study of 3639 patients in community practice.
    Wolfe F; Michaud K; Burke TA; Zhao SZ
    J Rheumatol; 2004 Feb; 31(2):355-8. PubMed ID: 14760808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.